{
    "organizations": [],
    "uuid": "aadb51c43a337b8b1ee4c575d4e207f467ebd6d6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-isofol-reports-positive-efficacy-d/brief-isofol-reports-positive-efficacy-data-for-modufolin-idUSFWN1P605U",
    "ord_in_thread": 0,
    "title": "BRIEF-Isofol Reports Positive Efficacy Data For Modufolin",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 11 (Reuters) - ISOFOL MEDICAL AB:\n* ISOFOL REPORTS POSITIVE EFFICACY DATA FOR MODUFOLINÂ® (ARFOLITIXORIN) FROM PATIENTS TREATED FOR METASTATIC COLORECTAL CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-11T15:50:00.000+02:00",
    "crawled": "2018-01-12T18:50:43.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "isofol",
        "medical",
        "ab",
        "isofol",
        "report",
        "positive",
        "efficacy",
        "data",
        "arfolitixorin",
        "patient",
        "treated",
        "metastatic",
        "colorectal",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}